MODULE 8 GLP-1 Supplementation Supplementation is a non-negotiable on GLP-1 medications
Being Patient: What do we know about once you go off drugs like Ozempic or Wegovy
The practical advantages of topical: easy to apply, local delivery, lower systemic exposure, and you don't need a needle
For example: Ozempic (for diabetes) typically starts at 0.25 mg weekly, increasing to 0.5 mg, then potentially to 1 mg (with a 2 mg option in some cases) Wegovy (for weight management) follows a different titration schedule up to 2.4 mg weekly Regular follow-up appointments will monitor: Blood glucose levels (HbA1c testing every 3-6 months) Weight changes Blood pressure Renal function Side effects and tolerability Injection technique Retinal screening (particularly important for people with diabetes on semaglutide) Timeline for effects : Regarding energy levels specifically, patients should understand that any improvements are likely to be gradual rather than immediate
Barreling into March 2025 and as states start to pull together their own budgets, Colorado is not the only state considering pulling back or in some way limiting their coverage either through state employee health plans or in Medicaid of GLP-1s for treating obesity
Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns H, et al
